Xponance’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,821	Closed	-$224K	–	1177
2021 Q4	$224K	Buy	3,821 +15	+0.4%	+$879	﹤0.01%	1104
2021 Q3	$226K	Sell	3,806 -584	-13%	-$34.7K	﹤0.01%	1096
2021 Q2	$381K	Buy	+4,390	New	+$381K	0.01%	1008